Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M207700200 on January 9, 2003

J. Biol. Chem., Vol. 278, Issue 11, 9862-9868, March 14, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/11/9862    most recent
M207700200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rehman, K. K.
Right arrow Articles by Robbins, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rehman, K. K.
Right arrow Articles by Robbins, P. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Protection of Islets by in Situ Peptide-mediated Transduction of the Ikappa B Kinase Inhibitor Nemo-binding Domain Peptide*

Khaja K. RehmanDagger , Suzanne Bertera§, Rita Bottino§, A. N. Balamurugan§, Jeffrey C. MaiDagger , Zhibao MiDagger , Massimo Trucco§, and Paul D. RobbinsDagger

From the Dagger  Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261 and the § Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261

We have previously demonstrated that adenoviral gene transfer of the NF-kappa B inhibitor Ikappa B to human islets results in protection from interleukin (IL)-1beta -mediated dysfunction and apoptosis. Here we report that human and mouse islets can be efficiently transduced by a cationic peptide transduction domain (PTD-5) without impairment of islet function. PTD mediated delivery of a peptide inhibitor of the IL-1beta -induced Ikappa B kinase (IKK), derived from IKKbeta (NBD; Nemo-binding domain), and completely blocked the detrimental effects of IL-1beta on islet function and NF-kappa B activity, in a similar manner to Ad-Ikappa B. We also demonstrate that mouse islets can be transduced in situ by infusion of the transduction peptide through the bile duct prior to isolation, resulting in 40% peptide transduction of the beta -cells. Delivery of the IKK inhibitor transduction fusion peptide (PTD-5-NBD) in situ to mouse islets resulted in improved islet function and viability after isolation. These results demonstrate the feasibility of using PTD-mediated delivery to transiently modify islets in situ to improve their viability and function during isolation, prior to transplantation.


* This work was supported by a grants from the Juvenile Diabetes Research Foundation, the Muscular Dystrophy Association, and National Institutes of Health Contract AR-6-2225.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom all correspondence should be addressed: Dept. of Molecular Genetics and Biochemistry, University of Pittsburgh, School of Medicine, W1246, Biomedical Science Tower, Pittsburgh, PA 15261. Tel.: 412-648-9268; Fax: 412-383-8837; E-mail: probb@pitt.edu.


Copyright © 2003 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
S. H. Dave, J. S. Tilstra, K. Matsuoka, F. Li, T. Karrasch, J. K. Uno, A. R. Sepulveda, C. Jobin, A. S. Baldwin, P. D. Robbins, et al.
Amelioration of Chronic Murine Colitis by Peptide-Mediated Transduction of the I{kappa}B Kinase Inhibitor NEMO Binding Domain Peptide
J. Immunol., December 1, 2007; 179(11): 7852 - 7859.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Z. Wang, T. Zhu, K. K. Rehman, S. Bertera, J. Zhang, C. Chen, G. Papworth, S. Watkins, M. Trucco, P. D. Robbins, et al.
Widespread and Stable Pancreatic Gene Transfer by Adeno-Associated Virus Vectors via Different Routes.
Diabetes, April 1, 2006; 55(4): 875 - 884.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
S K Richards, L E Parton, I Leclerc, G A Rutter, and R M Smith
Over-expression of AMP-activated protein kinase impairs pancreatic {beta}-cell function in vivo
J. Endocrinol., November 1, 2005; 187(2): 225 - 235.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. B. Hammar, J.-C. Irminger, K. Rickenbach, G. Parnaud, P. Ribaux, D. Bosco, D. G. Rouiller, and P. A. Halban
Activation of NF-{kappa}B by Extracellular Matrix Is Involved in Spreading and Glucose-stimulated Insulin Secretion of Pancreatic Beta Cells
J. Biol. Chem., August 26, 2005; 280(34): 30630 - 30637.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. N. Samli, M. J. McGuire, C. B. Newgard, S. A. Johnston, and K. C. Brown
Peptide-Mediated Targeting of the Islets of Langerhans
Diabetes, July 1, 2005; 54(7): 2103 - 2108.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
X. Zhou, X.-P. Gao, J. Fan, Q. Liu, K. N. Anwar, R. S. Frey, and A. B. Malik
LPS activation of Toll-like receptor 4 signals CD11b/CD18 expression in neutrophils
Am J Physiol Lung Cell Mol Physiol, April 1, 2005; 288(4): L655 - L662.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Abdelli, J. Ansite, R. Roduit, T. Borsello, I. Matsumoto, T. Sawada, N. Allaman-Pillet, H. Henry, J. S. Beckmann, B. J. Hering, et al.
Intracellular Stress Signaling Pathways Activated During Human Islet Preparation and Following Acute Cytokine Exposure
Diabetes, November 1, 2004; 53(11): 2815 - 2823.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Zeender, K. Maedler, D. Bosco, T. Berney, M. Y. Donath, and P. A. Halban
Pioglitazone and Sodium Salicylate Protect Human {beta}-Cells against Apoptosis and Impaired Function Induced by Glucose and Interleukin-1{beta}
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5059 - 5066.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. Zhang, A. Richter, J. Suriawinata, S. Harbaran, J. Altomonte, L. Cong, H. Zhang, K. Song, M. Meseck, J. Bromberg, et al.
Elevated Vascular Endothelial Growth Factor Production in Islets Improves Islet Graft Vascularization
Diabetes, April 1, 2004; 53(4): 963 - 970.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement